Agenebio

Therapeutic to treat amnestic mild cognitive impairment (aMCI) due to Alzheimer’s disease.

placeBaltimore, Maryland, United States calendar_todayFounded 2008 groups1 employees language agenebio.com

Registered entities

Innovation

19 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 6,191 times.

YearFilings
20153
20166
20174
20186
20198
20208
20218
202211
202310
202410
202510
20263

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%
Coming soon